Name of organisation
1) Department/Research groupPharmacoepidemiology and Drug Safety Research Group
2) Organisation/affiliationUniversity of Oslo
Short Name in the inventoryPharmaSafe
Administrative Contact
Title Professor
Last name Nordeng
First name Hedvig
Address line 1PB 1068 Blindern
Address line 2
Address line 3
CityOslo
Postcode0316
CountryNorway
Phone number (incl. country code)47-22856604
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Professor
Last name Nordeng
First name Hedvig
Address line 1PB 1068 Blindern, 0316 Oslo
Address line 2
Address line 3
CityOslo
Postcode
CountryNorway
Phone number (incl. country code)
Alternative phone number
Fax number (incl. country code)
2. Description
The PharmacoEpidemiology & Drug Safety Research Group covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.
The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, biostatistics, mathematics, health economics and pharmacotherapy.
3. Category
University based
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Clinician
No
Yes
Clinical Pharmacologist
No
Yes
Pharmacist
Yes
No
Geneticist/Pharmacogeneticist
Yes
No
IT specialist
Yes
No
Ethics expertise
No
Yes
Legal expertise
No
Yes
Regulatory expertise
No
Yes
Mathematician
Yes
No
Bioinformatician
Yes
No
Psychologist
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Congenital Malformations
Disorders of the central nervous system
Endocrine disorders
Gynaecology
Infectious diseases
Neonates
Paediatrics
Pregnancy
Psychiatry
Lactation
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Drug Utilisation
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Between 150 and 1499
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
Yes
System used:
National health registries
Interactive voice response systems
Call centre
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
NorPD6
11. Registries established by centre
None
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Networks registered with ENCePP
ENTIS